BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 1230 | Download: 1403
 |
Received |
|
2013-07-30 09:05 |
 |
Peer-Review Started |
|
2013-07-30 21:50 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-08-28 10:56 |
 |
Revised |
|
2013-09-02 07:10 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-10-16 11:18 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-10-16 12:15 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-11-18 11:39 |
 |
Publish the Manuscript Online |
|
2013-11-29 02:07 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Role of IL28B genotype in older hepatitis C virus-infected patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tatsuo Kanda, Shingo Nakamoto, Shuang Wu and Osamu Yokosuka |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. kandat-cib@umin.ac.jp |
| Key Words |
Hepatitis C virus; Interferon lambda 3; Interleukin-28B; Older patients; Telaprevir |
| Core Tip |
The exact mechanisms of the effects of interleukin-28B (IL28B) genotype on the treatment response in chronic hepatitis C patients are unclear. However, IL28B genotype is useful for the continued successful treatment of older patients infected with hepatitis C virus (HCV) and avoiding adverse events. Until the eventual availability of interferon-free regimens, it is important to determine IL28B genotype before treating HCV-infected individuals, especially in the screening of older patients. |
| Publish Date |
2013-11-29 02:07 |
| Citation |
Kanda T, Nakamoto S, Wu S, Yokosuka O. Role of IL28B genotype in older hepatitis C virus-infected patients. World J Immunol 2013; 3(3): 54-61 |
| URL |
http://www.wjgnet.com/2219-2824/full/v3/i3/54.htm |
| DOI |
http://dx.doi.org/10.5411/wji.v3.i3.54 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.